Skip to main content

Niagen Bioscience, Inc. (CDXC) Stock Forecast


Stock Price Forecast

March 31, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Niagen Bioscience, Inc. chart...

About the Company

Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.

Exchange

Nasdaq

$91M

Total Revenue

125

Employees

$536M

Market Capitalization

-666.15

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on Niagen Bioscience, Inc.

Niagen Bioscience Inc (NAGE) Q2 2025: Everything You Need To Know Ahead Of Earnings

13d ago, source: Yahoo Finance

Niagen Bioscience Inc (NASDAQ:NAGE) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 ...

Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

10d ago, source: Yahoo Finance

As you might know, Niagen Bioscience, Inc. (NASDAQ:NAGE) just kicked off its latest quarterly results with some very strong numbers. It was overall a positive result, with revenues beating ...

Niagen Bioscience, Inc. Reports First Quarter 2025 ... - Morningstar

3mon ago, source: Morningstar

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook Total net sales of $30.5 million, up $8.3 million or 38% year-over-year, gross margin of 63.4%, net ...

What 4 Analyst Ratings Have To Say About Niagen Bioscience

2mon ago, source: Nasdaq

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative ...

Breaking Down Niagen Bioscience: 4 Analysts Share Their Views

7d ago, source: Benzinga

Analysts have recently evaluated Niagen Bioscience and provided 12-month price targets. The average target is $16.0, accompanied by a high estimate of $23.00 and a low estimate of $12.00. This current ...

Niagen Bioscience, Inc. (NAGE) Q1 2025 Earnings Call Transcript

3mon ago, source: Seeking Alpha

Call Start: 16:30 January 1, 0000 5:16 PM ETNiagen Bioscience, Inc.Q1 2025 - Earnings Conference CallMay 7, 2025, 04:30 PM ETCompany ParticipantsWesley Yu - ...

Niagen Bioscience, Inc. Rings the Nasdaq Stock Market Closing Bell

5mon ago, source: Nasdaq

Niagen Bioscience, Inc. (Nasdaq: NAGE), the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research, visits the Nasdaq MarketSite in Times Square celebrating ...

Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates

11d ago, source: None

Niagen Bioscience (NAGE) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to break-even earnings per share a year ago. These ...

Niagen Bioscience to Participate in the BIO 2025 International ...

2mon ago, source: Morningstar

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced ...

Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference

14d ago, source: Yahoo Finance UK

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that ...

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results ...

3mon ago, source: Seeking Alpha

The Company announced its corporate name change to Niagen Bioscience, Inc. and commenced trading under the new Nasdaq ticker “NAGE,” effective March 19, 2025.

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
Ascend Wellness Holdings, Inc. AAWH Predict 137.09 None 5.02
AIBOTICS, INC. AIBT Predict 0.09 None None
Ayr Wellness Inc. AYRWF Predict 0.00 None 0.00
biote Corp. BTMD Predict 388.34 15.74 -2.98
Target Group Inc. CBDY Predict 1.05 None None
Niagen Bioscience, Inc. CDXC Predict 536.48 -666.15 11.64
Canopy Growth Corp CGC Predict 201.86 -0.33 0.41
Cronos Group Inc. CRON Predict 950.72 51.42 0.88
Curaleaf Holdings, Inc. CURLF Predict 2299.64 None 2.67
C21 Investments Inc. CXXIF Predict 37.99 None 1.32
CYANOTECH CORP CYAN Predict 2.17 -0.50 0.27
FITLIFE BRANDS, INC. FTLF Predict 119.64 19.28 3.07
Glass House Brands Inc. GHBWF Predict 29.62 None 0.26
Glass House Brands Inc. GLASF Predict 796.33 None 6.85
Glucose Health, Inc. GLUC Predict 0.47 None None
Jushi Holdings Inc. JUSHF Predict 114.33 None None
Mind Medicine (MindMed) Inc. MNMD Predict 837.02 -3.08 4.51
MANNATECH INC MTEX Predict 17.30 -55.42 2.28
Niagen Bioscience, Inc. NAGE Predict 850.47 47.97 13.25
NATURAL ALTERNATIVES INTERNATIONAL INC NAII Predict 26.16 -3.32 0.33
Cordyceps Sunshine Biotech Holdings Co., Ltd. RAJAF Predict 1020.08 None None
Raphael Pharmaceutical Inc. RAPH Predict 4.32 None None
SMART FOR LIFE, INC. SMFL Predict 0.00 0.00 0.00
Synergy CHC Corp. SNYR Predict 32.54 -551.25 -2.08
Trulieve Cannabis Corp. TCNNF Predict 1417.39 None 1.16
Cannaisseur Group Inc. TCRG Predict 15.70 None None
Tilray Brands, Inc. TLRY Predict 684.42 -4.14 0.25
UPEXI, INC. UPXI Predict 278.84 -10.63 150.67
USANA HEALTH SCIENCES INC USNA Predict 570.16 13.57 1.08

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...